Exact Mass: 305.1192

Exact Mass Matches: 305.1192

Found 500 metabolites which its exact mass value is equals to given mass value 305.1192, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Convicine

6-Amino-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)pyrimidine-2,4(1H,3H)-dione

C10H15N3O8 (305.0859)


Convicine is a glycoside. Convicine is a natural product found in Vicia faba and Vicia narbonensis with data available.

   

Pirimiphos-methyl

O-(2-(diethylamino)-6-Methyl-4-pyrimidinyl) O,O- dimethylphosphorothioate lic

C11H20N3O3PS (305.0963)


CONFIDENCE standard compound; INTERNAL_ID 4028 CONFIDENCE standard compound; INTERNAL_ID 2575 CONFIDENCE standard compound; INTERNAL_ID 8410 D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Imazamox

5-(Methoxymethyl)-2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid

C15H19N3O4 (305.1375)


2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid is a pyridinemonocarboxylic acid that is nicotinic acid which is substituted substituted at position 5 by a methoxymethyl group and at position 2 by a 4,5-dihydro-1H-imidazol-2-yl group, that in turn is substituted by isopropyl, methyl, and oxo groups at positions 4, 4, and 5, respectively. It is a pyridinemonocarboxylic acid, an ether, an imidazolone and a member of imidazolines. Imazamox is a member of the imidazolinone class of herbicides. It is registered for post-emergence control of broadleaf weeds and grass in alfalfa, edible legumes and soybeans. It is a systemic herbicide that moves throughout the plant tissue and prevents plants from producing an essential enzyme, acetolactate synthase (ALS), which is not found in animals. This enzyme is key for the biosynthesis of branched chain amino acids. Susceptible plants will stop growing soon after treatment, but plant death and decomposition will occur over several weeks.

   

BUPROFEZIN

Pesticide5_Buprofezin_C16H23N3OS_(2Z)-2-(tert-Butylimino)-3-(1-methylethyl)-5-phenyl-1,3,5-thiadiazinan-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10057; ORIGINAL_PRECURSOR_SCAN_NO 10056 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10079; ORIGINAL_PRECURSOR_SCAN_NO 10078 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10113; ORIGINAL_PRECURSOR_SCAN_NO 10111 ORIGINAL_ACQUISITION_NO 10127; CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10127; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10097; ORIGINAL_PRECURSOR_SCAN_NO 10096 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10129; ORIGINAL_PRECURSOR_SCAN_NO 10128

   

Zaleplon

N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide

C17H15N5O (305.1277)


Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Cetraxate

Cetraxate

C17H23NO4 (305.1627)


A cyclohexanecarboxylate ester that consists of 4-(2-carboxyethyl)phenyl cyclohexanecarboxylate bearing an aminomethyl substituent at the 4-position. C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents

   

Fenoldopam

6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol

C16H16ClNO3 (305.0819)


Fenoldopam is only found in individuals that have used or taken this drug. It is a dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation. [PubChem]Fenoldopam is a rapid-acting vasodilator. It is an agonist for D1-like dopamine receptors and binds with moderate affinity to α2-adrenoceptors. It has no significant affinity for D2-like receptors, α1 and β-adrenoceptors, 5HT1 and 5HT2 receptors, or muscarinic receptors. Fenoldopam is a racemic mixture with the R-isomer responsible for the biological activity. The R-isomer has approximately 250-fold higher affinity for D1-like receptors than does the S-isomer. In non-clinical studies, fenoldopam had no agonist effect on presynaptic D2-like dopamine receptors, or α or β -adrenoceptors, nor did it affect angiotensin-converting enzyme activity. Fenoldopam may increase norepinephrine plasma concentration. C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Convolamine

(8-BROMO-1-NAPHTHYL)METHANOL

C17H23NO4 (305.1627)


Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids

   

Racanisodamine

(6S)-6-Hydroxyhyoscyamine

C17H23NO4 (305.1627)


   

Entacapone

(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide

C14H15N3O5 (305.1012)


Entacapone is an inhibitor drug of catechol O-methyltransferase, which catalyzes the reaction between catechol and S-adenosyl-L-methionine to produce guaiacol and S-adenosyl-L-homocysteine. [HMDB] Entacapone is an inhibitor drug of catechol O-methyltransferase, which catalyzes the reaction between catechol and S-adenosyl-L-methionine to produce guaiacol and S-adenosyl-L-homocysteine. D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   
   

Lunacridine

(+/-)-Lunacridine

C17H23NO4 (305.1627)


   

Phenamil

3,5-Diamino-6-chloro-N-(N-phenylcarbamimidoyl)pyrazine-2-carboximidate

C12H12ClN7O (305.0792)


   

6-Oxolividamine

6-Oxolividamine

C12H23N3O6 (305.1587)


   

4-Oxolividamine

4-Oxolividamine; 3-Deoxy-4-oxoparomamine

C12H23N3O6 (305.1587)


An aminoglycoside that is 4alpha,6alpha-diaminocyclohexane-1beta,2alpha,3beta-triol in which the pro-R hydroxy group has been converted into its 2-amino-2,3-dideoxy-alpha-D-erythro-hexopyranosid-4-ulose derivative.

   

anisodamine

[(3S,6S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].

   

Ascorbigen

(3S,3aS,6S,6aR)-3,3a,6-trihydroxy-3-[(1H-indol-3-yl)methyl]-hexahydrofuro[3,2-b]furan-2-one

C15H15NO6 (305.0899)


Ascorbigen (CAS: 8075-98-7) belongs to the class of organic compounds known as isosorbides. These are organic polycyclic compounds containing an isosorbide (1,4-dianhydrosorbitol) moiety, which consists of two -oxolan-3-ol rings. Ascorbigen is possibly neutral. Ascorbigen is found, on average, in the highest concentration within guava and mung beans. Ascorbigen has also been detected, but not quantified, in bitter gourds and brassicas. Ascorbigen is present in plants, especially cabbage and other cruciferous plants. This could make ascorbigen a potential biomarker for the consumption of these foods. Present in plants, especies cabbage and other crucifers. Ascorbigen is found in many foods, some of which are mung bean, guava, brassicas, and bitter gourd.

   

N-Acetyldehydroanonaine

1-{3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14,16,18-heptaen-11-yl}ethan-1-one

C19H15NO3 (305.1052)


N-Acetyldehydroanonaine is found in fruits. N-Acetyldehydroanonaine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). N-Acetyldehydroanonaine is found in herbs and spices and fruits.

   

Zanthodioline

3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-2H,3H,4H,5H,6H-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


Zanthodioline is found in fruits. Zanthodioline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper

   

Benzosimuline

8,13,17,17-tetramethyl-18-oxa-8-azatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one

C20H19NO2 (305.1416)


Benzosimuline is found in fruits. Benzosimuline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper

   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


Syndesine is found in animal foods. Syndesine is an intramolecular crosslink of collagen. An intramolecular crosslink of collagen. Syndesine is found in animal foods.

   

Threonyltryptophan

(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanoic acid

C15H19N3O4 (305.1375)


Threonyltryptophan is a dipeptide composed of threonine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Methionyl-Arginine

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-5-carbamimidamidopentanoic acid

C11H23N5O3S (305.1522)


Methionyl-Arginine is a dipeptide composed of methionine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tryptophyl-Threonine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-hydroxybutanoate

C15H19N3O4 (305.1375)


Tryptophyl-Threonine is a dipeptide composed of tryptophan and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Arginylmethionine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C11H23N5O3S (305.1522)


Arginylmethionine is a dipeptide composed of arginine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

3-[(4-carboxy-3-hydroxy-4-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an (2S,3R)-3-hydroxy-2-methylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyhexanedioylcarnitine

3-[(5-carboxy-3-hydroxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


3-hydroxyhexanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyhexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyhexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethyl-2-hydroxybutanedioylcarnitine

3-[(3-carboxy-3-ethyl-3-hydroxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


2-Ethyl-2-hydroxybutanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethyl-2-hydroxybutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethyl-2-hydroxybutanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethyl-2-hydroxybutanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

1-(1-Naphthylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol

1-[(naphthalen-1-yl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C20H19NO2 (305.1416)


   

6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoic acid

C17H23NO4 (305.1627)


   

2-((N-(1-(1H-Imidazol-4-yl)-2-propyl)imino)phenylmethyl)phenol

2-({[1-(1H-imidazol-5-yl)propan-2-yl]imino}(phenyl)methyl)phenol

C19H19N3O (305.1528)


   

Applaud

2-Tert-butylimino-3-isopropyl-5-phenyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazin-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Cetraxate

4-(2-Carboxyethyl)phenyl-trans-4-aminomethylcyclohexane carboxylate hydrochloride

C17H23NO4 (305.1627)


   

Ciprofloxacin-7-ethylenediamine

7-[(2-aminoethyl)amino]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C15H16FN3O3 (305.1176)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

cis-Entacapone

2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide

C14H15N3O5 (305.1012)


   

Convicine

6-amino-2-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydropyrimidin-4-one

C10H15N3O8 (305.0859)


   

6-Fluoro-1-methyl-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid

6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

C15H16FN3O3 (305.1176)


   

m-Hydroxybenzoylecgonine

8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-[(3-hydroxybenzoyl)oxy]-8-methyl-, (1R,2R,3S,5S)-

C16H19NO5 (305.1263)


   

N-Hydroxynorcocaine

methyl 3-(benzoyloxy)-8-hydroxy-8-azabicyclo[3.2.1]octane-2-carboxylate

C16H19NO5 (305.1263)


   

p-hydroxybenzoylecgonine

3-(4-hydroxybenzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate

2,2-Diethyl 5-hydroxy-3-phenyl-3,4-dihydro-2H-pyrrole-2,2-dicarboxylic acid

C16H19NO5 (305.1263)


   

Pentoprilat

1-(4-carboxy-2,4-dimethylbutanoyl)-2,3-dihydro-1H-indole-2-carboxylic acid

C16H19NO5 (305.1263)


   

Rohitukine

5,7-dihydroxy-8-(3-hydroxy-1-methylpiperidin-4-yl)-2-methyl-4H-chromen-4-one

C16H19NO5 (305.1263)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

7-(Diethylphosphinoyloxy)-3-cyano-4-methylcoumarin

3-Cyano-4-methyl-2-oxo-2H-chromen-7-yl diethylphosphinic acid

C15H16NO4P (305.0817)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

1-(Naphthalen-2-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol

1-[(naphthalen-2-yl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C20H19NO2 (305.1416)


   

6-[5-(4-Carbamimidoylphenyl)-2-furyl]pyridine-3-carboxamidine

6-[5-(4-carbamimidoylphenyl)furan-2-yl]pyridine-3-carboximidamide

C17H15N5O (305.1277)


   

indole-3-acetyl-methionine

N-[1-Carboxy-3-(methylsulphanyl)propyl]-2-(1H-indol-3-yl)ethanecarboximidic acid

C15H17N2O3S- (305.096)


Indole-3-acetyl-methionine is also known as iaa-met. Indole-3-acetyl-methionine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-methionine can be found in a number of food items such as arctic blackberry, garlic, wax gourd, and chicory roots, which makes indole-3-acetyl-methionine a potential biomarker for the consumption of these food products.

   

Threoninyl-Tryptophan

2-[(2-amino-1,3-dihydroxybutylidene)amino]-3-(1H-indol-3-yl)propanoic acid

C15H19N3O4 (305.1375)


   

Anisodamine

7(c)micro-hydroxyhyoscyamine;Raceanisodamine; alpha-(Hydroxymethyl)benzeneacetic acid 6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Tropic acid 6-hydroxy-3-tropanyl ester

C17H23NO4 (305.1627)


6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate is a natural product found in Hyoscyamus niger with data available. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Anisodamine has been investigated for the treatment of Intestinal Diseases. 6-Hydroxyhyoscyamine is a natural product found in Duboisia myoporoides, Anisodus tanguticus, and Hyoscyamus albus with data available. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].

   

Tuberostemoamide

Tuberostemoamide

C17H23NO4 (305.1627)


   

Rohitukine

Rohitukine

C16H19NO5 (305.1263)


A member of the class of chromones that is 4H-chromen-4-one in which the hydrogens at positions 2,5,7 and 8 are replaced by methyl, hydroxy, hydroxy, and (3S,4R)-3-hydroxy-1-methylpiperidin-4-yl groups, respectively. It is an alkaloid initially isolated from Amoora rohituka and is a precursor of the anti-cancer compound flavopiridol.

   

Passiguatemalin

Passiguatemalin

C12H19NO8 (305.1111)


   

DTXSID20439752

DTXSID20439752

C15H15NO6 (305.0899)


   

Knightalbinol

Knightalbinol

C17H23NO4 (305.1627)


   
   

(-)-Nitropeptin

(-)-Nitropeptin

C11H19N3O7 (305.1223)


   
   
   

Pancratinine D

Pancratinine D

C16H19NO5 (305.1263)


   

N-Acetyldehydroanonaine

1-{3,5-dioxa-11-azapentacyclo[10.7.1.0^{2,6}.0^{8,20}.0^{14,19}]icosa-1,6,8(20),12,14,16,18-heptaen-11-yl}ethan-1-one

C19H15NO3 (305.1052)


   

R-Benzodiazepinedione

R-Benzodiazepinedione

C18H15N3O2 (305.1164)


   

(2S,4R)-2-Carboxy-4-(E)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt

(2S,4R)-2-Carboxy-4-(E)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt

C16H19NO5 (305.1263)


   

7beta-Hydroxyhyoscyamine

(+)-7b-Hydroxyhyoscyamine

C17H23NO4 (305.1627)


   
   

m-Hydroxybenzoylecgonine

m-Hydroxybenzoylecgonine

C16H19NO5 (305.1263)


   

Maybridge3_002653

Maybridge3_002653

C13H14F3NO4 (305.0875)


   
   

1-(1-isoquinolyl)-2-methylpropyl benzoate

1-(1-isoquinolyl)-2-methylpropyl benzoate

C20H19NO2 (305.1416)


   
   

Metazachlor BH 479-11

Metazachlor BH 479-11

C15H19N3O2S (305.1198)


CONFIDENCE standard compound; INTERNAL_ID 2650

   

UNII-6LUU9T79QN

UNII-6LUU9T79QN

C16H19NO5 (305.1263)


   

Phellibilidine

Phellibilidine

C17H23NO4 (305.1627)


   

3alpha-vanillyl-N-formylnortropane|confolidine

3alpha-vanillyl-N-formylnortropane|confolidine

C16H19NO5 (305.1263)


   

MCULE-2231490264

MCULE-2231490264

C16H19NO5 (305.1263)


   

Decarbomethoxy naucl echine

Decarbomethoxy naucl echine

C19H19N3O (305.1528)


   

Goshuyuamide I

Goshuyuamide I

C19H19N3O (305.1528)


   

13-hydroxyisopyrodysinoic acid

13-hydroxyisopyrodysinoic acid

C17H23NO4 (305.1627)


   

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

C19H19N3O (305.1528)


   
   

1,5-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)propyl]-2H-pyrrol-2-one

1,5-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)propyl]-2H-pyrrol-2-one

C16H19NO5 (305.1263)


   
   

L-alanyl-L-homoserinyl-L-aspartic acid

L-alanyl-L-homoserinyl-L-aspartic acid

C11H19N3O7 (305.1223)


   

AKOS030687758

AKOS030687758

C17H23NO4 (305.1627)


   

SCHEMBL5807496

SCHEMBL5807496

C17H23NO4 (305.1627)


   

SCHEMBL10832629

SCHEMBL10832629

C18H15N3O2 (305.1164)


   

(E)-4-Methoxy-2-(3,4-methylenedioxystyryl)quinoline|2-(3,4-methylenedioxystyryl)-4-methoxyquinoline

(E)-4-Methoxy-2-(3,4-methylenedioxystyryl)quinoline|2-(3,4-methylenedioxystyryl)-4-methoxyquinoline

C19H15NO3 (305.1052)


   
   
   
   

isophellibilidine

isophellibilidine

C17H23NO4 (305.1627)


   

2-(3,4-dihydro-2-hydroxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine A

2-(3,4-dihydro-2-hydroxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine A

C17H11N3O3 (305.08)


   

stemona-lactam P

stemona-lactam P

C17H23NO4 (305.1627)


   

SCHEMBL16164835

SCHEMBL16164835

C16H19NO5 (305.1263)


   

(-)-kunstleramide|(2E,4E)-7-(3,4-dimethoxyphenyl)-N-ethyl-6-(R)-hydroxyhepta-2,4-dienamide

(-)-kunstleramide|(2E,4E)-7-(3,4-dimethoxyphenyl)-N-ethyl-6-(R)-hydroxyhepta-2,4-dienamide

C17H23NO4 (305.1627)


   
   

8-(4-O-methyl-alpha-ribopyranosyloxy)-2-methylquinoline

8-(4-O-methyl-alpha-ribopyranosyloxy)-2-methylquinoline

C16H19NO5 (305.1263)


   

2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione

2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione

C18H15N3O2 (305.1164)


   
   

Physochlain|Physochlaine

Physochlain|Physochlaine

C17H23NO4 (305.1627)


   

norcoronatine

norcoronatine

C17H23NO4 (305.1627)


   

Beta-Naucleonine|Naucleonine

Beta-Naucleonine|Naucleonine

C19H19N3O (305.1528)


   

Wuzhuyurutine B

Wuzhuyurutine B

C17H11N3O3 (305.08)


   
   
   

O3-Demethylhippeastidine

O3-Demethylhippeastidine

C17H23NO4 (305.1627)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Imazamox

Imazamox

C15H19N3O4 (305.1375)


2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid is a pyridinemonocarboxylic acid that is nicotinic acid which is substituted substituted at position 5 by a methoxymethyl group and at position 2 by a 4,5-dihydro-1H-imidazol-2-yl group, that in turn is substituted by isopropyl, methyl, and oxo groups at positions 4, 4, and 5, respectively. It is a pyridinemonocarboxylic acid, an ether, an imidazolone and a member of imidazolines. Imazamox is a member of the imidazolinone class of herbicides. It is registered for post-emergence control of broadleaf weeds and grass in alfalfa, edible legumes and soybeans. It is a systemic herbicide that moves throughout the plant tissue and prevents plants from producing an essential enzyme, acetolactate synthase (ALS), which is not found in animals. This enzyme is key for the biosynthesis of branched chain amino acids. Susceptible plants will stop growing soon after treatment, but plant death and decomposition will occur over several weeks.

   

Entacapone

Entacapone

C14H15N3O5 (305.1012)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

fenoldopam

fenoldopam

C16H16ClNO3 (305.0819)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Zaleplon

Zaleplon

C17H15N5O (305.1277)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Convolvamine

Convolvamine

C17H23NO4 (305.1627)


Annotation level-1

   

Hexose + C4H5N3O2

Hexose + C4H5N3O2

C10H15N3O8 (305.0859)


Annotation level-3

   

1H-1,2,4-Triazole-1-propanoic acid, 3-ethyl-4,5-dihydro-5-oxo-4-(2-phenoxyethyl)-

1H-1,2,4-Triazole-1-propanoic acid, 3-ethyl-4,5-dihydro-5-oxo-4-(2-phenoxyethyl)-

C15H19N3O4 (305.1375)


   
   
   
   
   
   
   
   
   
   
   
   

Desethyleneciprofloxacin

7-(2-aminoethylamino)-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

C15H16FN3O3 (305.1176)


   
   
   
   
   
   

N-Hydroxynorcocaine

N-Hydroxynorcocaine

C16H19NO5 (305.1263)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Terbutaline-1-sulfate

Terbutaline-1-sulfate

C12H19NO6S (305.0933)


   

3-O-Methylisoproterenol Sulfate

3-O-Methylisoproterenol Sulfate

C12H19NO6S (305.0933)


   

Arg-met

2-[2-amino-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C11H23N5O3S (305.1522)


A dipeptide formed from L-arginine and L-methionine residues.

   

Met-arg

2-(2-amino-5-carbamimidamidopentanamido)-4-(methylsulfanyl)butanoic acid

C11H23N5O3S (305.1522)


A dipeptide formed from L-methionine and L-arginine residues.

   

THR-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanoic acid

C15H19N3O4 (305.1375)


A dipeptide composed of L-threonine and L-tryptophan joined by a peptide linkage.

   

TRP-THR

2-(2-amino-3-hydroxybutanamido)-3-(1H-indol-3-yl)propanoic acid

C15H19N3O4 (305.1375)


   

Ascorbigen

3,3a,6-trihydroxy-3-(1H-indol-3-ylmethyl)-hexahydrofuro[3,2-b]furan-2-one

C15H15NO6 (305.0899)


An indolyl carbohydrate that consists of (3aS,6S,6aR)-3,3a,6-trihydroxy-3-tetrahydrofuro[3,2-b]furan-2-one in which position 3 is substituted by an indol-3-ylmethyl group. Formed from indole-3-carbinol and ascorbic acid in brassica vegetables.

   

Zanthodioline

3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-2H,3H,4H,5H,6H-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


   

benzosimuline

8,13,17,17-tetramethyl-18-oxa-8-azatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one

C20H19NO2 (305.1416)


   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


   

2-chloro-n-[4-(4-ethoxyphenoxy)phenyl]acetamide

2-chloro-n-[4-(4-ethoxyphenoxy)phenyl]acetamide

C16H16ClNO3 (305.0819)


   

2-amino-4-(furan-2-yl)-3-nitro-6-phenylbenzonitrile

2-amino-4-(furan-2-yl)-3-nitro-6-phenylbenzonitrile

C17H11N3O3 (305.08)


   

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)

C18H15N3O2 (305.1164)


   

4-(4-FORMYL-PHENOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(4-FORMYL-PHENOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

2-chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide

2-chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide

C16H20ClN3O (305.1295)


   

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

C16H23NO3Si (305.1447)


   
   

cis-entacapone

cis-entacapone

C14H15N3O5 (305.1012)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors

   

(2S,4S)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

(2S,4S)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

C19H19N3O (305.1528)


   

3-Methyl-2-(4-propylphenyl)quinoline-4-carboxylic acid

3-Methyl-2-(4-propylphenyl)quinoline-4-carboxylic acid

C20H19NO2 (305.1416)


   

enrofloxacin lactate

enrofloxacin lactate

C15H16ClN3O2 (305.0931)


   

3-(2-CARBOXY-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER

3-(2-CARBOXY-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER

C16H19NO5 (305.1263)


   

5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE

5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE

C17H15N5O (305.1277)


   

N-BOC-4-PHENYLNIPECOTIC ACID

N-BOC-4-PHENYLNIPECOTIC ACID

C17H23NO4 (305.1627)


   

4-(4-Carboxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester

4-(4-Carboxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester

C17H23NO4 (305.1627)


   

3-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

3-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

7-Chloro-1H-benzo[d]imidazole

7-Chloro-1H-benzo[d]imidazole

C14H15N3O3S (305.0834)


   
   

(S)-N-BOC-4-FLUOROPHENYLGLYCINE

(S)-N-BOC-4-FLUOROPHENYLGLYCINE

C17H23NO4 (305.1627)


   

2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

C17H23NO4 (305.1627)


   

2-amino-6-(furan-2-yl)-3-nitro-4-phenylbenzonitrile

2-amino-6-(furan-2-yl)-3-nitro-4-phenylbenzonitrile

C17H11N3O3 (305.08)


   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(P-TOLYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(P-TOLYL)PYRROLIDINE-3-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

Cbz-D-Cyclohexylalanine

Cbz-D-Cyclohexylalanine

C17H23NO4 (305.1627)


   

Trimorpholinophosphine oxide

Trimorpholinophosphine oxide

C12H24N3O4P (305.1504)


   

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

C15H20BNO5 (305.1434)


   

4-(ETHYLCARBAMOYL)-3,6-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

4-(ETHYLCARBAMOYL)-3,6-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

C16H13F2NO3 (305.0863)


   
   

P,P-Diphenyl-N-(phenylmethylene)phosphinic amide

P,P-Diphenyl-N-(phenylmethylene)phosphinic amide

C19H16NOP (305.0969)


   

(3S,4R)-1-tert-butoxycarbonyl-3-phenyl-piperidine-4-carboxylic ac id

(3S,4R)-1-tert-butoxycarbonyl-3-phenyl-piperidine-4-carboxylic ac id

C17H23NO4 (305.1627)


   

BOC--BENZYL-DL-PRO-OH

BOC--BENZYL-DL-PRO-OH

C17H23NO4 (305.1627)


   

methyl 2-(oxan-4-ylidene)-2-(phenylmethoxycarbonylamino)acetate

methyl 2-(oxan-4-ylidene)-2-(phenylmethoxycarbonylamino)acetate

C16H19NO5 (305.1263)


   

(2-(N-Benzylsulfamoyl)-5-methylphenyl)boronic acid

(2-(N-Benzylsulfamoyl)-5-methylphenyl)boronic acid

C14H16BNO4S (305.0893)


   

N-Ethyl-N-(4-methoxybenzyl)benzenesulfonamide

N-Ethyl-N-(4-methoxybenzyl)benzenesulfonamide

C16H19NO3S (305.1086)


   

Orphenadrine hydrochloride

Orphenadrine hydrochloride

C18H24ClNO (305.1546)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AB - Ethers chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

ethyl 2-methyl-4,5-diphenyl-1H-pyrrole-3-carboxylate

ethyl 2-methyl-4,5-diphenyl-1H-pyrrole-3-carboxylate

C20H19NO2 (305.1416)


   

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

C19H19N3O (305.1528)


   

2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOIC ACID

2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOIC ACID

C13H14F3NO4 (305.0875)


   

2-[(1-NAPHTHYLACETYL)AMINO]BENZOIC ACID

2-[(1-NAPHTHYLACETYL)AMINO]BENZOIC ACID

C19H15NO3 (305.1052)


   

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

C16H23N3OS (305.1562)


   

H-Ala-Ala-Ala-OMe acetate salt

H-Ala-Ala-Ala-OMe acetate salt

C12H23N3O6 (305.1587)


   

(S)-(-)-N-(3-PENTYL)-1-PHENYLETHYLAMINEHYDROCHLORIDE

(S)-(-)-N-(3-PENTYL)-1-PHENYLETHYLAMINEHYDROCHLORIDE

C16H19NO3S (305.1086)


   

naphthol as acetate

naphthol as acetate

C19H15NO3 (305.1052)


   

1-(2-Fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride

1-(2-Fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride

C14H13ClFN5 (305.0843)


   

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

C19H20BNO2 (305.1587)


   

2-tert-Butyl-1-methyl-4-(trimethylstannyl)-1H-imidazole

2-tert-Butyl-1-methyl-4-(trimethylstannyl)-1H-imidazole

C11H25N2Sn (305.104)


   
   

2-CHLORO-6-METHOXYISONICOTINICACID

2-CHLORO-6-METHOXYISONICOTINICACID

C13H14F3NO4 (305.0875)


   

Bifemelane hydrochloride

Bifemelane hydrochloride

C18H24ClNO (305.1546)


   

2,4-bis(2-methylphenoxy)aniline

2,4-bis(2-methylphenoxy)aniline

C20H19NO2 (305.1416)


   

6-((1S)-1-Aminoethyl)-N-(3,4,5-trimethoxyphenyl)-1,2,4-triazin-3-amine

6-((1S)-1-Aminoethyl)-N-(3,4,5-trimethoxyphenyl)-1,2,4-triazin-3-amine

C14H19N5O3 (305.1488)


   
   

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C15H20BNO5 (305.1434)


   

2-borono-1-[(2-methylpropan-2-yl)oxycarbonyl]indole-5-carboxylic acid

2-borono-1-[(2-methylpropan-2-yl)oxycarbonyl]indole-5-carboxylic acid

C14H16BNO6 (305.1071)


   

N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline

N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline

C20H16FNO (305.1216)


   

(3R,4S)-1-tert-Butoxycarbonyl-3-acetoxy-4-phenyl-2-azetidinone

(3R,4S)-1-tert-Butoxycarbonyl-3-acetoxy-4-phenyl-2-azetidinone

C16H19NO5 (305.1263)


   

ethyl 2-methyl-1,5-diphenylpyrrole-3-carboxylate

ethyl 2-methyl-1,5-diphenylpyrrole-3-carboxylate

C20H19NO2 (305.1416)


   

5-(N-BENZYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID

5-(N-BENZYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID

C14H16BNO4S (305.0893)


   

5-(4-chlorophenyl)-9-methyl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamine

5-(4-chlorophenyl)-9-methyl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamine

C15H20ClN5 (305.1407)


   

benzoic acid, diphenylmethanamine

benzoic acid, diphenylmethanamine

C20H19NO2 (305.1416)


   

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

C18H24ClNO (305.1546)


   
   

2-amino-1-(4-benzylpiperazin-1-yl)ethanone,dihydrochloride

2-amino-1-(4-benzylpiperazin-1-yl)ethanone,dihydrochloride

C13H21Cl2N3O (305.1062)


   

benzyl 1-(2-methoxy-2-oxoacetyl)piperidine-2-carboxylate

benzyl 1-(2-methoxy-2-oxoacetyl)piperidine-2-carboxylate

C16H19NO5 (305.1263)


   

4-FLUOROBENZOICACID

4-FLUOROBENZOICACID

C18H15N3S (305.0987)


   

methyl red hydrochloride

methyl red hydrochloride

C15H16ClN3O2 (305.0931)


   

Methyl 4-amino-3-fluoro-5-nitro-2-(phenylamino)benzoate

Methyl 4-amino-3-fluoro-5-nitro-2-(phenylamino)benzoate

C14H12FN3O4 (305.0812)


   

Nicofibrate

3-Pyridinylmethyl 2-(4-chlorophenoxy)-2-methylpropanoate

C16H16ClNO3 (305.0819)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   
   

N-BENZYL-2-PIPERAZIN-1-YL-ACETAMIDE DIHYDROCHLORIDE

N-BENZYL-2-PIPERAZIN-1-YL-ACETAMIDE DIHYDROCHLORIDE

C13H21Cl2N3O (305.1062)


   

1-[2-[(2-HYDROXYETHYL)THIO]ETHYL]-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID

1-[2-[(2-HYDROXYETHYL)THIO]ETHYL]-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID

C16H19NO3S (305.1086)


   

Ethyl 5-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate

Ethyl 5-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate

C15H19N3O4 (305.1375)


   

4-(Dimethylamino)phenyldiphenylphosphine

4-(Dimethylamino)phenyldiphenylphosphine

C20H20NP (305.1333)


   

tert-butyl 3-(3-bromopropyl)piperidine-1-carboxylate

tert-butyl 3-(3-bromopropyl)piperidine-1-carboxylate

C13H24BrNO2 (305.099)


   

tert-Butyl 4-(3-bromopropyl)piperidine-1-carboxylate

tert-Butyl 4-(3-bromopropyl)piperidine-1-carboxylate

C13H24BrNO2 (305.099)


   

Dribendazole

Dribendazole

C15H19N3O2S (305.1198)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

[4-(2,4-difluorophenyl)-2-(methylcarbamoyl)phenyl] acetate

[4-(2,4-difluorophenyl)-2-(methylcarbamoyl)phenyl] acetate

C16H13F2NO3 (305.0863)


   

Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate

Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate

C16H19NO5 (305.1263)


   

Ethyl phthalimidomalonate

Ethyl phthalimidomalonate

C15H15NO6 (305.0899)


   

Bzl-L-Phe-OMe * HCl

Bzl-L-Phe-OMe * HCl

C17H20ClNO2 (305.1182)


   

boc-dl-7-azatryptophan

boc-dl-7-azatryptophan

C15H19N3O4 (305.1375)


   

VU 0357121

VU 0357121

C17H17F2NO2 (305.1227)


VU 0357121 is a positive and highly selective mGlu5R allosteric modulator (PAM) with an EC50 of 33 nM. VU 0357121 is inactive or very weakly antagonizing at other mGlu receptor subtypes[1].

   

2-(4-TERT-BUTYLPHENYL)QUINOLINE-4-CARBOXYLICACID

2-(4-TERT-BUTYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C20H19NO2 (305.1416)


   

Tenofovir Monohydrate

9-[(R)-2-(Phosphonomethoxy)propyl]adenine monohydrate

C9H16N5O5P (305.0889)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.

   
   

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

C18H24ClNO (305.1546)


   

Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester

Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester

C16H19NO5 (305.1263)


   

Benzoic acid, 4-[(6-deoxy-α-L-mannopyranosyl)amino]-, sodium salt

Benzoic acid, 4-[(6-deoxy-α-L-mannopyranosyl)amino]-, sodium salt

C13H16NNaO6 (305.0875)


   

N-(1-(2-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

N-(1-(2-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

C16H19NO3S (305.1086)


   

N-(1-(3-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

N-(1-(3-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

C16H19NO3S (305.1086)


   

7-Chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid ethyl ester

7-Chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid ethyl ester

C16H16ClNO3 (305.0819)


   

6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline

6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline

C17H20ClNO2 (305.1182)


   

4-Nitro-N,N-diphenyl-1,3-benzenediamine

4-Nitro-N,N-diphenyl-1,3-benzenediamine

C18H15N3O2 (305.1164)


   

tert-Butyl 3-morpholin-3-yl-propionate oxalate

tert-Butyl 3-morpholin-3-yl-propionate oxalate

C13H23NO7 (305.1474)


   

1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride

1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride

C11H26Cl3N3 (305.1192)


   

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

C15H20BNO5 (305.1434)


   

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

C16H23NO3Si (305.1447)


   

sodium,1,1-biphenyl,naphthalene

sodium,1,1-biphenyl,naphthalene

C22H18Na+ (305.1306)


   

2-METHYL-7-[3-(TRIFLUOROMETHYL)PYRIDIN-2-YL]QUINAZOLIN-4-OL

2-METHYL-7-[3-(TRIFLUOROMETHYL)PYRIDIN-2-YL]QUINAZOLIN-4-OL

C15H10F3N3O (305.0776)


   
   
   

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

C15H20BNO5 (305.1434)


   

2-(Diphenylphosphino)benzaldehyde oxime

2-(Diphenylphosphino)benzaldehyde oxime

C19H16NOP (305.0969)


   

(S)-1-(2-(DIPHENYLPHOSPHINO)PHENYL)ETHANAMINE

(S)-1-(2-(DIPHENYLPHOSPHINO)PHENYL)ETHANAMINE

C20H20NP (305.1333)


   

N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide

N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide

C17H15N5O (305.1277)


   

1-[4-(aminomethyl)phenyl]-N,N-dimethylpiperidin-4-amine,dihydrochloride

1-[4-(aminomethyl)phenyl]-N,N-dimethylpiperidin-4-amine,dihydrochloride

C14H25Cl2N3 (305.1425)


   

1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

C16H19NO5 (305.1263)


   

4,4-Dimethoxy-triphenylamine

4,4-Dimethoxy-triphenylamine

C20H19NO2 (305.1416)


   

1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

C17H15N5O (305.1277)


   

1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

C17H15N5O (305.1277)


   

Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate

Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate

C16H19NO5 (305.1263)


   

3-(5-ethyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione

3-(5-ethyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione

C15H19N3S2 (305.102)


   

2-Quinolinecarboxylic acid (1-oxo-1-phenylpropan-2-yl) ester

2-Quinolinecarboxylic acid (1-oxo-1-phenylpropan-2-yl) ester

C19H15NO3 (305.1052)


   

Methionyl-Arginine

Methionyl-Arginine

C11H23N5O3S (305.1522)


   

Terbutaline 1-sulfate

Terbutaline 1-sulfate

C12H19NO6S (305.0933)


   

1-methyl-5-[(4-methylphenyl)sulfanyl]-3-phenyl-1H-pyrazole-4-carbonitrile

1-methyl-5-[(4-methylphenyl)sulfanyl]-3-phenyl-1H-pyrazole-4-carbonitrile

C18H15N3S (305.0987)


   

Thiazole orange cation

Thiazole orange cation

C19H17N2S+ (305.1112)


   

1-(2-Fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea

1-(2-Fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea

C14H12FN3O4 (305.0812)


   

2-({[2-(Methoxycarbonyl)phenyl]amino}carbonyl)cyclohexanecarboxylic acid

2-({[2-(Methoxycarbonyl)phenyl]amino}carbonyl)cyclohexanecarboxylic acid

C16H19NO5 (305.1263)


   

N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide

N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide

C14H15N3O3S (305.0834)


   

1-(2-Furyl)-3-[(2-phenoxyphenyl)amino]-2-propen-1-one

1-(2-Furyl)-3-[(2-phenoxyphenyl)amino]-2-propen-1-one

C19H15NO3 (305.1052)


   

N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine

N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine

C18H15N3O2 (305.1164)


   

gamma-Glutamyl-threoninyl-glycine

gamma-Glutamyl-threoninyl-glycine

C11H19N3O7 (305.1223)


   

9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid

9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid

C20H19NO2 (305.1416)


   

1-N-(4-Sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium

1-N-(4-Sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium

C16H21N2O2S+ (305.1324)


   

Anilinomethyl gluco-phenylimidazole

Anilinomethyl gluco-phenylimidazole

C15H19N3O4 (305.1375)


   

6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

C17H15N5O (305.1277)


   

3-(4-Fluorophenyl)-1-hydroxy-2-(pyridin-4-YL)-1H-pyrrolo[3,2-B]pyridine

3-(4-Fluorophenyl)-1-hydroxy-2-(pyridin-4-YL)-1H-pyrrolo[3,2-B]pyridine

C18H12FN3O (305.0964)


   

N-(8,9,10-Trihydroxy-7-hydroxymethyl-2,4-dioxo-6-oxa-1,3-diaza-spiro[4.5]dec-3-YL-acetamide

N-(8,9,10-Trihydroxy-7-hydroxymethyl-2,4-dioxo-6-oxa-1,3-diaza-spiro[4.5]dec-3-YL-acetamide

C10H15N3O8 (305.0859)


   

[(4Z)-2-(1-Amino-2-hydroxyethyl)-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-YL]acetic acid

[(4Z)-2-(1-Amino-2-hydroxyethyl)-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-YL]acetic acid

C14H15N3O5 (305.1012)


   
   

(R)-benzodiazepinedione

(R)-benzodiazepinedione

C18H15N3O2 (305.1164)


   

(indol-3-yl)acetyl-L-methionine

(indol-3-yl)acetyl-L-methionine

C15H17N2O3S- (305.096)


   

3-Hydroxyhexanedioylcarnitine

3-Hydroxyhexanedioylcarnitine

C13H23NO7 (305.1474)


   

2-Ethyl-2-hydroxybutanedioylcarnitine

2-Ethyl-2-hydroxybutanedioylcarnitine

C13H23NO7 (305.1474)


   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

C13H23NO7 (305.1474)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione

(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione

C18H15N3O2 (305.1164)


   

Disipal

Disipal

C18H24ClNO (305.1546)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

Alnert

Alnert

C18H24ClNO (305.1546)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

p-Nitrophenylphosphocholine

p-Nitrophenylphosphocholine

C11H18N2O6P+ (305.0902)


   

[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea

[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea

C17H15N5O (305.1277)


   

2-[(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid

2-[(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid

C16H19NO5 (305.1263)


   

7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile

7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile

C18H15N3O2 (305.1164)


   

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

C16H23N3OS (305.1562)


   

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide

C15H19N3O2S (305.1198)


   

N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

C18H15N3O2 (305.1164)


   

N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide

N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide

C15H19N3O2S (305.1198)


   

5-(1,4-Diazepan-1-ylsulfonyl)-4-methylisoquinoline

5-(1,4-Diazepan-1-ylsulfonyl)-4-methylisoquinoline

C15H19N3O2S (305.1198)


   

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

C16H23N3OS (305.1562)


   

5-[(2-Methyl-5-nitroanilino)methyl]-2-(methylthio)-4-pyrimidinamine

5-[(2-Methyl-5-nitroanilino)methyl]-2-(methylthio)-4-pyrimidinamine

C13H15N5O2S (305.0946)


   

2-hydroxy-N-[(2E)-1-(5-nitro-2H-tetrazol-2-yl)propan-2-ylidene]benzohydrazide

2-hydroxy-N-[(2E)-1-(5-nitro-2H-tetrazol-2-yl)propan-2-ylidene]benzohydrazide

C11H11N7O4 (305.0872)


   

3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione

3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione

C18H15N3O2 (305.1164)


   

Thr-Ala-Asp

Thr-Ala-Asp

C11H19N3O7 (305.1223)


A tripeptide composed of L-threonine, L-alanine, and L-aspartic acid joined by peptide linkages.

   

N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide

N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide

C16H19NO3S (305.1086)


   

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide

C16H19NO3S (305.1086)


   

(indol-3-yl)butanoyl-L-cysteine

(indol-3-yl)butanoyl-L-cysteine

C15H17N2O3S- (305.096)


   

N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine

N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine

C17H15N5O (305.1277)


   

N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

C17H15N5O (305.1277)


   

7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

C17H15N5O (305.1277)


   

7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

C17H15N5O (305.1277)


   

5-Acetyloxy-2-[[cyclohexyl(oxo)methyl]amino]benzoic acid

5-Acetyloxy-2-[[cyclohexyl(oxo)methyl]amino]benzoic acid

C16H19NO5 (305.1263)


   

4-(2,3-Dihydroindol-1-ylmethyl)-7-ethyl-1-benzopyran-2-one

4-(2,3-Dihydroindol-1-ylmethyl)-7-ethyl-1-benzopyran-2-one

C20H19NO2 (305.1416)


   

N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide

N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide

C17H15N5O (305.1277)


   

1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione

1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione

C18H15N3O2 (305.1164)


   

N-(4-fluorophenyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]acetamide

N-(4-fluorophenyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]acetamide

C14H12FN3O4 (305.0812)


   

(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine

(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine

C18H15N3O2 (305.1164)


   

2-(4-Ethyl-piperazin-1-yl)-5-(5-methyl-furan-2-ylmethylene)-thiazol-4-one

2-(4-Ethyl-piperazin-1-yl)-5-(5-methyl-furan-2-ylmethylene)-thiazol-4-one

C15H19N3O2S (305.1198)


   

2,5-Dimethyl-4-(4-methyl-1-piperidinyl)-6-thieno[2,3-d]pyrimidinecarboxylic acid

2,5-Dimethyl-4-(4-methyl-1-piperidinyl)-6-thieno[2,3-d]pyrimidinecarboxylic acid

C15H19N3O2S (305.1198)


   

N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide

N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide

C15H19N3O2S (305.1198)


   

L-Tryptophyl-L-threonine

L-Tryptophyl-L-threonine

C15H19N3O4 (305.1375)


   

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

C16H23N3OS (305.1562)


   

N-methyl-N-[5-(5-methyl-2-pyrazinyl)-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide

N-methyl-N-[5-(5-methyl-2-pyrazinyl)-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide

C13H15N5O2S (305.0946)


   

N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide

N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide

C17H15N5O (305.1277)


   
   
   
   
   

N(6)-L-homocysteinyl-N(2)-acetyl-L-lysine

N(6)-L-homocysteinyl-N(2)-acetyl-L-lysine

C12H23N3O4S (305.1409)


   
   
   
   
   
   
   

L-homocysteinyl-N(6)-acetyl-L-lysine

L-homocysteinyl-N(6)-acetyl-L-lysine

C12H23N3O4S (305.1409)


   
   
   
   
   
   
   
   
   
   
   
   

2-[(2S,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide

N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide

C17H15N5O (305.1277)


   

2-[(2S,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2S,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2S,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-acetyl-L-methionyl-L-asparagine

N-acetyl-L-methionyl-L-asparagine

C11H19N3O5S (305.1045)


   

(E)-nesocodin (oxo-form)

(E)-nesocodin (oxo-form)

C16H19NO5 (305.1263)


   

(E)-nesocodin (alcohol-form)

(E)-nesocodin (alcohol-form)

C16H19NO5 (305.1263)


   

1-[(E)-3-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)prop-1-enyl]pyrrolidine-2-carboxylic acid

1-[(E)-3-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)prop-1-enyl]pyrrolidine-2-carboxylic acid

C16H19NO5 (305.1263)


   

3-[3-Ethyl-5-oxo-4-(2-phenoxyethyl)-1,2,4-triazol-1-yl]propanoic acid

3-[3-Ethyl-5-oxo-4-(2-phenoxyethyl)-1,2,4-triazol-1-yl]propanoic acid

C15H19N3O4 (305.1375)


   

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

Pirimiphos-methyl

Pirimiphos-methyl

C11H20N3O3PS (305.0963)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   
   

Arginyl-methionine

Arginyl-methionine

C11H23N5O3S (305.1522)


   

Tryptophylthreonine

Tryptophylthreonine

C15H19N3O4 (305.1375)


   

Threoninyl-Tryptophan

Threoninyl-Tryptophan

C15H19N3O4 (305.1375)


   

6-Amino-5-beta-D-glucopyranosyloxyuracil

6-Amino-5-beta-D-glucopyranosyloxyuracil

C10H15N3O8 (305.0859)


   

FPTQ

FPTQ

C17H12FN5 (305.1077)


FPTQ is potent mGluR1 antagonist with IC50 values of 6 nM and 1.4 nM for human and mouse mGluR1 respectively[1]. FPTQ has anti-oxidant and anti-inflammatory effects in vitro and in vivo[2].

   

GN44028

GN44028

C18H15N3O2 (305.1164)


GN44028 is a potent and orally active hypoxia inducible factor (HIF)-1α inhibitor, with an IC50 of 14 nM. GN44028 inhibits hypoxia-induced HIF-1α transcriptional activity without suppressing HIF-1α mRNA expression, HIF-1α protein accumulation, or HIF-1α/HIF-1β heterodimerization. GN44028 can be used in the research of cancers[1][3].

   

N-Propargyladenosine

N-Propargyladenosine

C13H15N5O4 (305.1124)


N-Propargyladenosine is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. N-Propargyladenosine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

1-{5-hydroxy-2,8-dimethylphenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

1-{5-hydroxy-2,8-dimethylphenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

C19H15NO3 (305.1052)


   

(2e)-3-(6,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

(2e)-3-(6,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

C16H19NO5 (305.1263)


   

(1s,15r,17r,18s,19r)-17,18-dihydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9-trien-12-ium-12-olate

(1s,15r,17r,18s,19r)-17,18-dihydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9-trien-12-ium-12-olate

C16H19NO5 (305.1263)


   

6,6,9,12-tetramethylisochromeno[4,3-c]quinolin-11-one

6,6,9,12-tetramethylisochromeno[4,3-c]quinolin-11-one

C20H19NO2 (305.1416)


   

(2z)-3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

(2z)-3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

C13H23NO5S (305.1297)


   

1-[2-(4-hydroxyphenyl)ethyl]-5-[(1s,2r)-1,2,3-trihydroxypropyl]pyrrole-2-carbaldehyde

1-[2-(4-hydroxyphenyl)ethyl]-5-[(1s,2r)-1,2,3-trihydroxypropyl]pyrrole-2-carbaldehyde

C16H19NO5 (305.1263)


   

2-[(4-amino-2,6-dihydroxypyrimidin-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(4-amino-2,6-dihydroxypyrimidin-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C10H15N3O8 (305.0859)


   

(1r,13s,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

(1r,13s,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

C16H19NO5 (305.1263)


   

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

C16H19NO5 (305.1263)


   

2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)butanedioic acid

2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)butanedioic acid

C11H19N3O7 (305.1223)


   

(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt

NA

C16H19NO5 (305.1263)


{"Ingredient_id": "HBIN006744","Ingredient_name": "(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt","Alias": "NA","Ingredient_formula": "C16H19NO5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

C16H19NO5 (305.1263)


   

(1r,2s,3r)-2,3-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopentane-1-carbonitrile

(1r,2s,3r)-2,3-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopentane-1-carbonitrile

C12H19NO8 (305.1111)


   

(3r,4s)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3r,4s)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


   

4,7,8,8-tetramethoxyfuro[2,3-b]quinolin-5-one

4,7,8,8-tetramethoxyfuro[2,3-b]quinolin-5-one

C15H15NO6 (305.0899)


   

2-[(1e)-2-(2h-1,3-benzodioxol-5-yl)ethenyl]-4-methoxyquinoline

2-[(1e)-2-(2h-1,3-benzodioxol-5-yl)ethenyl]-4-methoxyquinoline

C19H15NO3 (305.1052)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-nitropentanedioic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-nitropentanedioic acid

C11H19N3O7 (305.1223)


   

(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

C18H15N3O2 (305.1164)


   

methyl (3e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

methyl (3e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

C16H19NO5 (305.1263)


   

2-[2-(2h-1,3-benzodioxol-5-yl)ethenyl]-4-methoxyquinoline

2-[2-(2h-1,3-benzodioxol-5-yl)ethenyl]-4-methoxyquinoline

C19H15NO3 (305.1052)


   

(4r,5r,6e,8e,11r)-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaene-3,5,11,14,16-pentol

(4r,5r,6e,8e,11r)-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaene-3,5,11,14,16-pentol

C16H19NO5 (305.1263)


   

4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

C12H19NO8 (305.1111)


   

3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

C13H23NO5S (305.1297)


   

13-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-11-carbaldehyde

13-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-11-carbaldehyde

C19H15NO3 (305.1052)


   

5,7-dihydroxy-8-[(3r,4s)-3-hydroxy-1-methylpiperidin-4-yl]-2-methylchromen-4-one

5,7-dihydroxy-8-[(3r,4s)-3-hydroxy-1-methylpiperidin-4-yl]-2-methylchromen-4-one

C16H19NO5 (305.1263)


   

(3s,4r)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3s,4r)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


   

3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

C18H15N3O2 (305.1164)


   

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

C19H19N3O (305.1528)


   

5-methoxy-2-[(2-methylquinolin-8-yl)oxy]oxane-3,4-diol

5-methoxy-2-[(2-methylquinolin-8-yl)oxy]oxane-3,4-diol

C16H19NO5 (305.1263)


   

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C18H15N3O2 (305.1164)


   

1-{3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-11-yl}ethanone

1-{3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-11-yl}ethanone

C19H15NO3 (305.1052)


   

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

C18H15N3O2 (305.1164)


   

(2s,3s)-2-amino-3-{[(2e)-3-[2-(3-methyloxiran-2-yl)phenyl]prop-2-enoyl]oxy}butanoic acid

(2s,3s)-2-amino-3-{[(2e)-3-[2-(3-methyloxiran-2-yl)phenyl]prop-2-enoyl]oxy}butanoic acid

C16H19NO5 (305.1263)


   

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

C12H19NO8 (305.1111)


   

methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate

methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate

C18H15N3O2 (305.1164)


   

(1r,4r)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

(1r,4r)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

C12H19NO8 (305.1111)


   

3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

C16H19NO5 (305.1263)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}butanedioic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}butanedioic acid

C11H19N3O7 (305.1223)


   

2-amino-3-(c-hydroxycarbonimidoyl)-3-(4-methoxy-1-methylquinolin-4-yl)propanoic acid

2-amino-3-(c-hydroxycarbonimidoyl)-3-(4-methoxy-1-methylquinolin-4-yl)propanoic acid

C15H19N3O4 (305.1375)


   

(1r,6r)-3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

(1r,6r)-3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

C16H19NO5 (305.1263)


   

1-hydroxy-5-methoxy-6-methyl-7-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindole-4-carboxylic acid

1-hydroxy-5-methoxy-6-methyl-7-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindole-4-carboxylic acid

C16H19NO5 (305.1263)


   

1-[2-(4-hydroxyphenyl)ethyl]-5-(1,2,3-trihydroxypropyl)pyrrole-2-carbaldehyde

1-[2-(4-hydroxyphenyl)ethyl]-5-(1,2,3-trihydroxypropyl)pyrrole-2-carbaldehyde

C16H19NO5 (305.1263)


   

methyl (4e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

methyl (4e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

C16H19NO5 (305.1263)